Evaluation of the COVID-19 testing strategy in PHC of a high-vulnerability health district in Brazil, 2020-2022.

Publication date: Jun 05, 2025

Considering the potential role of primary health care (PHC) in the response to COVID-19, a formative evaluation (FE) was carried out between December 2021 and February 2022 to understand its work process against COVID-19 in a high-vulnerability health district in Brazil, identifying the difficulties in carrying out tests and the best practices for the implementation of the intervention “Expansion of testing, quarantine, e-health and telemonitoring strategies to combat COVID-19 in Brazil” (TQT). FEs are used to guide the implementation of health interventions. This FE was based on a situational diagnosis of the territories and PHC health units of the health district under study, with approximately 400,000 inhabitants, in which the TQT Project would later be implemented. A qualitative study was conducted based on 22 semistructured interviews and three focus groups (FGs) involving 19 PHC professionals. The interviews and FGs were analysed in terms of their thematic content. There was a lack of coordination in implementing actions; COVID-19 testing was concentrated in a few PHC units, generating work overload and weakness of other health programs in these units; the health units’ physical structure was inadequate, and human resources were insufficient; and no criteria were identified for defining the number of tests offered per day per unit. The FE identified barriers to testing and supported the design of the TQT, including the adaptations needed to implement actions. The concentration of testing in a few units is an important barrier to access; it is suggested that testing actions should be deconcentrated in as many health units as possible.

Open Access PDF

Concepts Keywords
Brazil COVID-19
February COVID-19 testing
Interviews Primary health care
Qualitative Workflow

Semantics

Type Source Name
disease MESH COVID-19
disease IDO role
disease IDO process
disease IDO intervention
disease MESH lack of coordination
pathway REACTOME Reproduction
disease MESH causes
drug DRUGBANK Creatinolfosfate
drug DRUGBANK Serine
disease MESH tics
disease IDO object
disease MESH oral health
disease MESH emergency
drug DRUGBANK Etoperidone
disease MESH uncertainty
disease IDO history
drug DRUGBANK Trestolone
drug DRUGBANK Erythropoietin
disease MESH rhinitis
drug DRUGBANK Coenzyme M
disease MESH complications
drug DRUGBANK Urokinase
disease MESH community transmission
disease MESH violence
disease MESH emotional distress
disease MESH insomnia
disease MESH anxiety
disease MESH family health
drug DRUGBANK Esomeprazole
disease MESH recrudescence
drug DRUGBANK Methylergometrine
disease IDO contact tracing
drug DRUGBANK Adenosine 5′-phosphosulfate
drug DRUGBANK Ribostamycin
drug DRUGBANK Alpha-Linolenic Acid

Original Article

(Visited 1 times, 1 visits today)